Shigeoka A O, Hall R T, Hemming V G, Allred C D, Hill H R
Infect Immun. 1978 Jul;21(1):34-40. doi: 10.1128/iai.21.1.34-40.1978.
A requirement for the classic complement pathway in opsonization of group B streptococci was observed by using both a chemiluminescence and a radiolabeled bacterial uptake technique. The classic pathway increased levels of opsonization for types Ia and II stock and wild strains and for some type III wild strains. In contrast, other type III wild strains and the type III stock strain had accelerated kinetics of uptake in the presence of an intact classic pathway, but the level of opsonization was unchanged from that with antibody alone. We could not demonstrate a significant role for the alternative pathway in opsonizing stock or wild strains of group B streptococci. Futhermore, electrophoretic and complement consumption analysis by hemolytic titration failed to reveal alternative pathway activation by the majority of strains of this group. Therapy aimed at supplying opsonins for these organisms will require the presence of type-specific antibody.
通过使用化学发光和放射性标记细菌摄取技术,观察到经典补体途径在B族链球菌调理作用中的必要性。经典途径提高了Ia型和II型储备菌株及野生菌株以及一些III型野生菌株的调理水平。相比之下,其他III型野生菌株和III型储备菌株在完整经典途径存在的情况下摄取动力学加快,但调理水平与单独使用抗体时相比没有变化。我们未能证明替代途径在B族链球菌储备菌株或野生菌株的调理作用中具有重要作用。此外,通过溶血滴定进行的电泳和补体消耗分析未能揭示该组大多数菌株对替代途径的激活。针对这些病原体提供调理素的治疗将需要存在型特异性抗体。